Cargando…
Pathogenic variants of sphingomyelin synthase SMS2 disrupt lipid landscapes in the secretory pathway
Sphingomyelin is a dominant sphingolipid in mammalian cells. Its production in the trans-Golgi traps cholesterol synthesized in the ER to promote formation of a sphingomyelin/sterol gradient along the secretory pathway. This gradient marks a fundamental transition in physical membrane properties tha...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531943/ https://www.ncbi.nlm.nih.gov/pubmed/36102623 http://dx.doi.org/10.7554/eLife.79278 |
_version_ | 1784802004644659200 |
---|---|
author | Sokoya, Tolulope Parolek, Jan Foged, Mads Møller Danylchuk, Dmytro I Bozan, Manuel Sarkar, Bingshati Hilderink, Angelika Philippi, Michael Botto, Lorenzo D Terhal, Paulien A Mäkitie, Outi Piehler, Jacob Kim, Yeongho Burd, Christopher G Klymchenko, Andrey S Maeda, Kenji Holthuis, Joost CM |
author_facet | Sokoya, Tolulope Parolek, Jan Foged, Mads Møller Danylchuk, Dmytro I Bozan, Manuel Sarkar, Bingshati Hilderink, Angelika Philippi, Michael Botto, Lorenzo D Terhal, Paulien A Mäkitie, Outi Piehler, Jacob Kim, Yeongho Burd, Christopher G Klymchenko, Andrey S Maeda, Kenji Holthuis, Joost CM |
author_sort | Sokoya, Tolulope |
collection | PubMed |
description | Sphingomyelin is a dominant sphingolipid in mammalian cells. Its production in the trans-Golgi traps cholesterol synthesized in the ER to promote formation of a sphingomyelin/sterol gradient along the secretory pathway. This gradient marks a fundamental transition in physical membrane properties that help specify organelle identify and function. We previously identified mutations in sphingomyelin synthase SMS2 that cause osteoporosis and skeletal dysplasia. Here, we show that SMS2 variants linked to the most severe bone phenotypes retain full enzymatic activity but fail to leave the ER owing to a defective autonomous ER export signal. Cells harboring pathogenic SMS2 variants accumulate sphingomyelin in the ER and display a disrupted transbilayer sphingomyelin asymmetry. These aberrant sphingomyelin distributions also occur in patient-derived fibroblasts and are accompanied by imbalances in cholesterol organization, glycerophospholipid profiles, and lipid order in the secretory pathway. We postulate that pathogenic SMS2 variants undermine the capacity of osteogenic cells to uphold nonrandom lipid distributions that are critical for their bone forming activity. |
format | Online Article Text |
id | pubmed-9531943 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-95319432022-10-05 Pathogenic variants of sphingomyelin synthase SMS2 disrupt lipid landscapes in the secretory pathway Sokoya, Tolulope Parolek, Jan Foged, Mads Møller Danylchuk, Dmytro I Bozan, Manuel Sarkar, Bingshati Hilderink, Angelika Philippi, Michael Botto, Lorenzo D Terhal, Paulien A Mäkitie, Outi Piehler, Jacob Kim, Yeongho Burd, Christopher G Klymchenko, Andrey S Maeda, Kenji Holthuis, Joost CM eLife Biochemistry and Chemical Biology Sphingomyelin is a dominant sphingolipid in mammalian cells. Its production in the trans-Golgi traps cholesterol synthesized in the ER to promote formation of a sphingomyelin/sterol gradient along the secretory pathway. This gradient marks a fundamental transition in physical membrane properties that help specify organelle identify and function. We previously identified mutations in sphingomyelin synthase SMS2 that cause osteoporosis and skeletal dysplasia. Here, we show that SMS2 variants linked to the most severe bone phenotypes retain full enzymatic activity but fail to leave the ER owing to a defective autonomous ER export signal. Cells harboring pathogenic SMS2 variants accumulate sphingomyelin in the ER and display a disrupted transbilayer sphingomyelin asymmetry. These aberrant sphingomyelin distributions also occur in patient-derived fibroblasts and are accompanied by imbalances in cholesterol organization, glycerophospholipid profiles, and lipid order in the secretory pathway. We postulate that pathogenic SMS2 variants undermine the capacity of osteogenic cells to uphold nonrandom lipid distributions that are critical for their bone forming activity. eLife Sciences Publications, Ltd 2022-09-14 /pmc/articles/PMC9531943/ /pubmed/36102623 http://dx.doi.org/10.7554/eLife.79278 Text en © 2022, Sokoya, Parolek et al https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Biochemistry and Chemical Biology Sokoya, Tolulope Parolek, Jan Foged, Mads Møller Danylchuk, Dmytro I Bozan, Manuel Sarkar, Bingshati Hilderink, Angelika Philippi, Michael Botto, Lorenzo D Terhal, Paulien A Mäkitie, Outi Piehler, Jacob Kim, Yeongho Burd, Christopher G Klymchenko, Andrey S Maeda, Kenji Holthuis, Joost CM Pathogenic variants of sphingomyelin synthase SMS2 disrupt lipid landscapes in the secretory pathway |
title | Pathogenic variants of sphingomyelin synthase SMS2 disrupt lipid landscapes in the secretory pathway |
title_full | Pathogenic variants of sphingomyelin synthase SMS2 disrupt lipid landscapes in the secretory pathway |
title_fullStr | Pathogenic variants of sphingomyelin synthase SMS2 disrupt lipid landscapes in the secretory pathway |
title_full_unstemmed | Pathogenic variants of sphingomyelin synthase SMS2 disrupt lipid landscapes in the secretory pathway |
title_short | Pathogenic variants of sphingomyelin synthase SMS2 disrupt lipid landscapes in the secretory pathway |
title_sort | pathogenic variants of sphingomyelin synthase sms2 disrupt lipid landscapes in the secretory pathway |
topic | Biochemistry and Chemical Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531943/ https://www.ncbi.nlm.nih.gov/pubmed/36102623 http://dx.doi.org/10.7554/eLife.79278 |
work_keys_str_mv | AT sokoyatolulope pathogenicvariantsofsphingomyelinsynthasesms2disruptlipidlandscapesinthesecretorypathway AT parolekjan pathogenicvariantsofsphingomyelinsynthasesms2disruptlipidlandscapesinthesecretorypathway AT fogedmadsmøller pathogenicvariantsofsphingomyelinsynthasesms2disruptlipidlandscapesinthesecretorypathway AT danylchukdmytroi pathogenicvariantsofsphingomyelinsynthasesms2disruptlipidlandscapesinthesecretorypathway AT bozanmanuel pathogenicvariantsofsphingomyelinsynthasesms2disruptlipidlandscapesinthesecretorypathway AT sarkarbingshati pathogenicvariantsofsphingomyelinsynthasesms2disruptlipidlandscapesinthesecretorypathway AT hilderinkangelika pathogenicvariantsofsphingomyelinsynthasesms2disruptlipidlandscapesinthesecretorypathway AT philippimichael pathogenicvariantsofsphingomyelinsynthasesms2disruptlipidlandscapesinthesecretorypathway AT bottolorenzod pathogenicvariantsofsphingomyelinsynthasesms2disruptlipidlandscapesinthesecretorypathway AT terhalpauliena pathogenicvariantsofsphingomyelinsynthasesms2disruptlipidlandscapesinthesecretorypathway AT makitieouti pathogenicvariantsofsphingomyelinsynthasesms2disruptlipidlandscapesinthesecretorypathway AT piehlerjacob pathogenicvariantsofsphingomyelinsynthasesms2disruptlipidlandscapesinthesecretorypathway AT kimyeongho pathogenicvariantsofsphingomyelinsynthasesms2disruptlipidlandscapesinthesecretorypathway AT burdchristopherg pathogenicvariantsofsphingomyelinsynthasesms2disruptlipidlandscapesinthesecretorypathway AT klymchenkoandreys pathogenicvariantsofsphingomyelinsynthasesms2disruptlipidlandscapesinthesecretorypathway AT maedakenji pathogenicvariantsofsphingomyelinsynthasesms2disruptlipidlandscapesinthesecretorypathway AT holthuisjoostcm pathogenicvariantsofsphingomyelinsynthasesms2disruptlipidlandscapesinthesecretorypathway |